北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第二临床医学院  > 血液科  > 期刊论文
学科主题: 临床医学
题名:
Low-dose MTX combined with low-dose methylprednisolone as a first-line therapy for the treatment of acute GVHD: safety and feasibility
作者: Wang, Y.; Xu, L. P.; Liu, K. Y.; Liu, D. H.; Wang, J.; Chen, H.; Chen, Y. H.; Han, W.; Huang, X. J.
关键词: acute GVHD ; MTX ; methylprednisolone
刊名: BONE MARROW TRANSPLANTATION
发表日期: 2011-06-01
DOI: 10.1038/bmt.2010.197
卷: 46, 期:6, 页:892-898
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Biophysics ; Oncology ; Hematology ; Immunology ; Transplantation
研究领域[WOS]: Biophysics ; Oncology ; Hematology ; Immunology ; Transplantation
关键词[WOS]: VERSUS-HOST-DISEASE ; STEM-CELL TRANSPLANTATION ; BONE-MARROW-TRANSPLANTATION ; GRAFT ; METHOTREXATE ; PREDNISONE ; TRIAL
英文摘要:

To study the efficacy and safety of a low dose of MTX combined with a low dose of methylprednisolone (MP) as a first-line therapy in the treatment of acute GVHD (aGVHD) after allogeneic hematopoietic SCT, 32 patients received i.v. MTX at a dose of 10 mg or oral MTX at a dose of 15 mg every 3-7 days (repeated at day 3 after the first dose and then at a weekly interval) combined with a low dose of MP (0.5 mg/kg/day) until a complete or partial response was achieved, or until treatment failure or intolerable side effects occurred. The overall treatment response rate was 81% (26/32 patients) and the response rate at day 28 was 75% (24/32 patients). The response rate for GVHD involving various organs was 88% (23/26) in the skin, 75% (3/4) in the liver and 81% (9/11) in the gut. Grade 3 toxicities occurred in only three patients presenting cytopenias. The estimated survival at 2 years was 77%. From this analysis, MTX in combination with a low dose of MP appears to be a well-tolerated, effective and inexpensive regime when used as a first-line treatment for aGVHD. Bone Marrow Transplantation (2011) 46, 892-898; doi: 10.1038/bmt.2010.197; published online 16 August 2010

语种: 英语
所属项目编号: 30725038 ; IRT 0702
项目资助者: National Outstanding Young Scientist&prime ; s Foundation of China ; Program for Innovative Research Team in University ; Leading Program of Clinical Faculty
WOS记录号: WOS:000291383100019
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/60685
Appears in Collections:北京大学第二临床医学院_血液科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: Peking Univ, Peoples Hosp, Inst Hematol, Beijing 100044, Peoples R China

Recommended Citation:
Wang, Y.,Xu, L. P.,Liu, K. Y.,et al. Low-dose MTX combined with low-dose methylprednisolone as a first-line therapy for the treatment of acute GVHD: safety and feasibility[J]. BONE MARROW TRANSPLANTATION,2011,46(6):892-898.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Wang, Y.]'s Articles
[Xu, L. P.]'s Articles
[Liu, K. Y.]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Wang, Y.]‘s Articles
[Xu, L. P.]‘s Articles
[Liu, K. Y.]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace